Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Tianjin CanSino Biotechnology Inc.
DescriptionRecombinant human type 5 adenovirus vector based Ebola vaccine
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase I
Standard IndicationEbola
Indication DetailsTreat Ebola
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today